clopidogrel bioequivalence - PD endpoint [Design Issues]

posted by ElMaestro  – Denmark, 2009-01-14 18:22 (6371 d 00:22 ago) – Posting: # 3030
Views: 9,770

Dear kshitij,

❝ 2. Can platelet aggregation be utilised for estimating the bioequivalence of the clopidogrel?


It might be possible, in which case you would probably have to give reasonable proof that your method gives better chance of detecting a clin. meaningful difference than if you evaluate the PK of parent compound, metabolites etc.
How on earth you can do this I cannot tell. But in case you try I would be the first to gamble on a referral at my local bookmaker.

Best regards
EM.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
160 visitors (0 registered, 160 guests [including 23 identified bots]).
Forum time: 19:44 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5